Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.
about
Endometriosis, angiogenesis and tissue factorIKK2 inhibition attenuates laser-induced choroidal neovascularizationTargeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin.A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degenerationInhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II.Complement factor h is critical in the maintenance of retinal perfusion.Animals as models of age-related macular degeneration: an imperfect measure of the truth.Animal models of choroidal and retinal neovascularization.Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosisRoles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization.Role of ocular complement factor H in a murine model of choroidal neovascularization.Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancerRelationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degenerationInhibitory role of adiponectin peptide I on rat choroidal neovascularization.Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.Evidence for enhanced tissue factor expression in age-related macular degeneration.Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization.Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.Immunological factors in the pathogenesis and treatment of age-related macular degeneration.Tissue factor with age-related macular degeneration.Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy.Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.Tissue factor pathway inhibitor: structure-function.Association of polymorphisms in complement component 3 with age-related macular degeneration in an Iranian population.A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs.The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets.Protection of tight junction between RPE cells with tissue factor targeting peptide
P2860
Q27013803-816E83BC-B4EC-4428-A2A0-11B5141F464CQ28539266-5D564AAF-0921-4343-BC76-ADC51EFEF89AQ33279027-09131E9A-AF63-40F9-A5D1-53C2AE86E54DQ33283093-C2EB50DD-F963-452D-BD4B-D1B6359295F6Q33415294-396C03AB-5828-4FE8-BA42-3FA0AD50839CQ33440992-6E686A15-7F6A-4A17-9AD4-F910BAB25116Q33471110-7A8654EC-1E4D-436A-973A-61AF255DED92Q33552165-110284D0-12E2-4212-8EE3-A9DDDE526A30Q33582933-AC53DBC2-CF73-44E7-BF38-7080BE4F5CE8Q33588136-0EDD4F37-6CD8-4F35-ACD0-90A6E23C9C30Q33597282-BE9B7939-5CB2-4C80-950C-13F5C04A4C9BQ33647292-6A652EF5-446B-46AC-A643-4008DCC1D4C6Q33683222-7AB6FE90-9FE3-4F5B-817B-D71F389FBE1DQ33715830-D0517216-25C5-43BA-9954-8474BD60B28BQ33880596-43CD0BD4-FD42-4E22-93B6-F7F121A17E83Q34076104-4B549019-BBF3-49DB-BB1E-1384CFD7495EQ34283258-CC8EA610-D1E7-448C-857C-22FF9BF0A79AQ34451693-42C51A7F-AF06-45DF-A354-6629F6765065Q34744314-6612AFF1-6A96-4DC9-883A-59B3A96C16DAQ34762840-FF2C779D-D5BE-496E-9223-DF5E32E52D3EQ34909956-7F461EEF-D583-45F7-816D-5DBBFA36C795Q35006931-168FA3A8-5E40-4CBD-BCD0-35C87AC1A48DQ35191438-BE8A60A7-DC55-447D-895E-6F5854B5DBF7Q36086191-5A297921-0A6C-44FF-B175-F482B863DB3AQ36358685-68FEFD80-1C95-474E-A4D1-12A6BECB52B6Q37633792-8B34CE15-E4EF-4D45-B523-3C5E6C3FD011Q37639757-6E31990F-2F71-45B4-BFE4-FB23FF0E55FBQ37702117-CF05AAD5-98A1-407F-8519-C828B6B5F932Q37971520-6085EB88-8C64-42DC-8125-D9E357C5BDA8Q39876637-6DD2E87D-4AF5-45A8-82B3-AECD10760152Q41113194-D7B5E37D-E3C1-4A3D-9BF2-5C96731FF3C9Q41764457-93D7CB25-02BA-4D0A-9924-621B820825A8Q47689628-79E1480A-0481-461E-B22C-D634073EC2A8Q52721270-7B4832AE-3D61-4887-9ABC-82DB9F41528BQ54962618-571D1307-23B6-45A3-8A95-7C6EAAF6A965Q58597167-9D41865F-43C5-452D-9FA9-A274FDCCF178
P2860
Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.
@ast
Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.
@en
type
label
Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.
@ast
Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.
@en
prefLabel
Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.
@ast
Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.
@en
P2093
P2860
P356
P1476
Immunotherapy for choroidal ne ...... ve (wet) macular degeneration.
@en
P2093
Alan Garen
Henry J Kaplan
Jeong-Hyeon Sohn
Jose M C Cruz
Nalini S Bora
Shin Goo Kang
Tongalp H Tezel
P2860
P304
P356
10.1073/PNAS.0438014100
P407
P577
2003-02-14T00:00:00Z